Five things for pharma marketers to know: Monday, June 18, 2018

Share this content:

BetterDoctor, a technology company that provides healthcare networks with provider directory data, has been bought by Quest Analytics. Terms of the deal weren't disclosed. The acquisition brings together two companies working to help healthcare systems access more accurate physician data. (Axios)

Longtime biotech analyst Eric Schmidt is joining CAR-T startup Allogene Therapeutics as CFO. Founded by former Kite Pharma CEO Arie Belldegrun, Allogene is thought to be headed towards an IPO. (STAT)

U.S. campaigns accounted for 42% of shortlisted entries in the Pharma Lions category at Cannes, up from one-third last year. Campaigns from Allergan, Boehringer Ingelheim, Novartis, Biogen, Pfizer, and Eli Lilly were recognized, among others. The winners will be announced on Monday. (MM&M)

A federal grand jury has indicted Theranos founder and CEO Elizabeth Holmes and president Ramesh Balwani on charges of defrauding investors and deceiving patients and physicians. Holmes has also stepped down as CEO of the once-unicorn, now disgraced blood-testing company. (New York Times)

Sixty-five percent of Americans are “very concerned” about the cost of health insurance, including premiums, deductibles, and copays, according to a Reuters/Ipsos poll. Of the nearly 75% of Americans who use prescription drugs, 58% are “very concerned” about how they'll pay for them. (Reuters)

Share this content:
Scroll down to see the next article